The June 2026 paper reports no trial results because it is a protocol for a planned double-blind randomized trial. Its findings cannot change acne care yet because no efficacy outcomes were available and the test treatment is only an add-on. It describes oral probiotics, live beneficial microbes, plus topical secretome, a product derived from mesenchymal stromal cells, for mild-to-moderate acne vulgaris. For adults with persistent breakouts past the teen years, that timing matters.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the 2026 paper actually published
- How the planned 8-week trial will work
- Why proven treatments still come first
- What adults with persistent acne can do now
What the 2026 paper actually published
BMJ Open describes the June 4, 2026 document as a protocol for a future double-blind randomized controlled trial, according to the BMJ Open protocol outline. It lays out rationale, design, and measurements. It does not report lesion counts or treatment effects.
The linked trial NCT06925386 was listed as not yet enrolling, according to the Veeva registry from Universitas Padjadjaran. A Phase 2 interventional study cannot report efficacy before participants start treatment. That status explains the absence of results.
How the planned 8-week trial will work
The Veeva listing says researchers plan to randomize 64 mild-to-moderate acne patients into four arms. Each arm combines standard therapy with active or placebo probiotic and active or placebo secretome over 8 weeks. This design isolates the added effect of each product.
The primary outcome is reduction in comedones and inflammatory papules and pustules, measured by Yolov8 machine detection, according to the ICH GCP registry mirror. Secondary measures include gut and skin markers such as tryptophan metabolites, collagen, pH, moisture, sebum and IL-6. Machine counting aims to make lesion scoring more consistent.
Why proven treatments still come first
The planned regimen adds oral HEXBIO probiotic and topical secretome to standard acne therapy, according to the Veeva listing. It does not test them as standalone replacements for antibiotics or retinoids. That adjunct design limits any near-term change in prescriptions.
A University of Miami systematic review of 33 studies in 2,112 patients aged 18-33 found within-group improvement, but between-group differences were not significant, according to the Medscape summary of the Dermatology and Therapy review. Current U.S. guidance gives strong recommendations to benzoyl peroxide, retinoids, antibiotics, oral doxycycline and isotretinoin for severe disease, according to the MDedge report on AAD guidance. Neither probiotics nor secretome has a strong recommendation.
What adults with persistent acne can do now
Persistent acne often continues from adolescence into adulthood, including in about 15-20% of adult women, according to the American Acne and Rosacea Society. Late-onset disease is defined from age 25. These readers should stay on proven care while results remain pending.
Ask your dermatologist to review your current standard regimen before adding any probiotic or secretome product. Bring a record of breakouts, products, and side effects. Do not stop prescribed retinoids or antibiotics to try an unproven add-on.
- Continue your prescribed benzoyl peroxide, retinoid, antibiotic, doxycycline, or isotretinoin plan as directed.
- Ask whether an added probiotic or skin product fits your history and acne severity.
- Track comedones, papules, pustules, dryness, and irritation for 8 weeks and share changes at follow-up.
You Might Also Like
- The 2026 Oral Probiotic and Topical Secretome Acne Trial Protocol: Why the Findings May Not Change Acne Care Yet for Adults With Persistent Acne
- Skin Microbiome Outcomes in the 2026 Probiotic Acne Review: Why the Findings May Not Change Acne Care Yet for Adults With Persistent Acne
- Probiotics for Acne in a 2026 Systematic Review and Meta-Analysis: Why the Findings May Not Change Acne Care Yet for Adults With Persistent Acne